MAM
XBIT icon

Meeder Asset Management’s XBiotech XBIT Stock Holding History

Meeder Asset Management’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,505
Closed -$105K – 2257
2020
Q3 		$105K Sell
5,505
-99
-2% -$1.71K 0.01% 774
2020
Q2 		$76K Buy
5,604
+2,035
+57% +$28.6K ﹤0.01% 829
2020
Q1 		$39K Buy
3,569
+1,422
+66% +$23.1K ﹤0.01% 1008
2019
Q4 		$40K Buy
+2,147
New +$27.6K ﹤0.01% 1098
2017
Q4 		– Sell
-177
Closed -$1K – 1819
2017
Q3 		$1K Sell
177
-40
-18% -$189 ﹤0.01% 1573
2017
Q2 		$1K Buy
217
+95
+78% +$910 ﹤0.01% 1564
2017
Q1 		$2K Buy
122
+107
+713% +$1.4K ﹤0.01% 1417
2016
Q4 		$0 Buy
+15
New +$200 ﹤0.01% 1073

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Meeder Asset Management's XBIT Position: Q4 2020 in Review

Meeder Asset Management sold out of XBiotech (XBIT) in Q4 2020, closing a stake of 5,505 shares — an estimated $105K sold.

Meeder Asset Management first reported a position in XBIT in Q4 2016 and held it in 8 quarters. The position peaked at $105K in Q3 2020. 66 funds tracked by Wall St. Rank hold XBIT as of Q4 2020.

  • Meeder Asset Management reported no remaining XBiotech position as of Q4 2020 after selling out during the quarter.
  • Meeder Asset Management sold 5,505 XBiotech shares in Q4 2020, an estimated $105K.
  • Meeder Asset Management first reported a position in XBiotech in Q4 2016 and held it in 8 quarters.
  • Meeder Asset Management's XBiotech position peaked at $105K in Q3 2020.
  • 66 funds tracked by Wall St. Rank held XBiotech as of Q4 2020.

Based on Meeder Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.